Palliative care services for patients with inoperable cancer and end-stage chronic medical conditions have been shown to improve quality of life, reduce consumption of medical services, and overall increase long-term survival. 1 In surgical populations, palliative care has grown in use, demonstrating improvement in outcomes with advocates suggesting that surgeons themselves should be proficient in primary palliative care skills for their patients. 2 Yet many questions remain unanswered when it comes to which populations would benefit from primary vs specialty palliative care services and who is best to provide those services. In this issue of JAMA Surgery, the study by Shinall et al 3 identified a clear and distinct surgical population-namely, patients with resectable cancer undergoing major operations with curative intent. The trial was well designed and faithfully executed. Palliative care specialist teams were clearly engaged to a high standard throughout the care pathway for patients randomized to the intervention. Thus, in the setting of a gold-standard randomized clinical trial with a very homogenous population, there was absence of significant benefit for routine specialty palliative care consultation.This is an important study despite the demonstrated absence of significant impact for routine palliative care consultation because it begs multiple fundamental questions. Clearly one may ask based on the current study and for future work:(1) What elective surgical populations are likely to benefit most